Showing results (331-340 of 372) with videos related to
Sort By:
Pageof 38
Biomedicines|October 26, 2024
Prognostic Value of Speckle Tracking Echocardiography-Derived Strain in Unmasking Risk for Arrhythmias in Children with MyocarditisNele Rolfs, Cynthia Huber, Bernd Opgen-Rhein, et al.Kidney International|December 15, 2011
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyOliver Gross, Christoph Licht, Hans J Anders, et al.Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.The New England Journal of Medicine|March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial FibrillationUlf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.Brain : a Journal of Neurology|October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progressionJeff Rodgers, Tim Friede, Frederick W Vonberg, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 17, 2025
Rationale and design of the HERZCHECK trial: Detection of early heart failure using telemedicine and cardiovascular magnetic resonance in structurally weak regions (NCT05122793)Sebastian Kelle, Anna Clara Nolden, Maximilian Leo Müller, et al.Circulation. Heart Failure|July 14, 2026
HERZCHECK: Early Detection of Subclinical Preheart Failure Using Mobile Cardiac Magnetic Resonance and Telemedicine in Rural and Underressourced RegionsSebastian Kelle, Maximilian Leo Müller, Rebecca Elisabeth Beyer, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countriesChristian Sticherling, Barbora Arendacka, Jesper Hastrup Svendsen, et al.BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.Pageof 38